Baritinib is a drug to treat rheumatoid arthritis. After outbreak of COVID-19, Benevolent AI Company discovered that AAK1 is a regulatory factor in the process of SARS-CoC-2 infection by generating a ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. TxGNN is the first AI model specifically developed to identify ...

Repurposing and repositioning have gained considerable attention from a range of stakeholders, including NIH, academic institutions, pharmaceutical companies, and even some technology companies, for ...

Finding a new medicine is never easy. But developing treatments for patients with rare diseases — conditions that afflict fewer than 200,000 people in the United States — is particularly challenging.

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, today announced that it has been named a leading innovator in AI drug ...

HERSHEY, Pa. — Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United Stated topped $722 billion, a trend that’s expected to continue. Yet, ...

In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

A team of U.S. clinicians has launched a first-of-its-kind observational study on how repurposed drugs with expired patents, such as ivermectin, might help in treating cancer. The study, led by the ...

Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study. A combination treatment incorporating three existing drugs -- tamsulosin, metoprolol and ...